Press Releases

Roswell Park Comprehensive Cancer Center is soon to welcome its newest culinary option, Joe’s Deli, to campus. The Buffalo-based delicatessen will offer signature fresh foods and smoothies in a café space in the Scott Bieler Clinical Sciences Center on the cancer center’s main campus.

In recognition of its efforts to promote diversity in nursing career development and reduce healthcare disparities, Roswell Park Comprehensive Cancer Center has received the 2022 Partnership of the Year Award from Buffalo Black Nurses Inc.

A targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates when tested in a large multicenter clinical trial conducted by the Children’s Oncology Group (COG) co-led by Roswell Park's Kara Kelly, MD. The study results have been reported in the New England Journal of Medicine.

Lung cancer is the leading cause of cancer death in the United States, accounting for almost 25% of all cancer deaths. Roswell Park is one of more than 50 organizations calling for greater awareness to get eligible people screened.

Roswell Park is proud to break ground on a new Community Outreach & Engagement Building at 907 Michigan Avenue in Buffalo. The project, which includes preservation of a home in Buffalo’s historic Fruit Belt neighborhood, will be the new hub for the cancer center’s extensive Community Outreach and Engagement (COE) team.

Recognized for her “extraordinary work and incredible spirit,” Roswell Park Comprehensive Cancer Center President & CEO Candace S. Johnson, PhD, was named an Advocacy in Action Award winner by Western New York’s Housing Opportunities Made Equal (HOME, Inc.).

A collaborative effort between investigators at Roswell Park Comprehensive Cancer Center and the Center for Molecular Immunology (CIM) in Havana, Cuba, has revealed a new strategy for correcting immune dysfunction in cancer patients.

A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute and Roswell Park Comprehensive Cancer Center report in a new study published today by the New England Journal of Medicine.

One of the core focuses of Roswell Park Comprehensive Cancer Center’s Department of Cancer Prevention & Control is to assess the impact of cancer across Western New York (WNY). This team has compiled a new resource to report to the community those cancers that are most prevalent, documenting noteworthy changes in cancer incidence, deaths from cancer and variations in these trends among people of different races or ethnicities.